Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

2.73
+0.03001.11%
Post-market: 2.69-0.0392-1.44%19:41 EDT
Volume:37.47K
Turnover:102.87K
Market Cap:1.94M
PE:-0.09
High:2.82
Open:2.81
Low:2.69
Close:2.70
52wk High:105.00
52wk Low:2.63
Shares:711.10K
Float Shares:707.00K
Volume Ratio:0.87
T/O Rate:5.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-31.4508
EPS(LYR):-428.8747
ROE:-160.91%
ROA:-76.69%
PB:0.37
PE(LYR):-0.01

Loading ...

Aethlon Medical: Pre-Revenue Status, Ongoing Cash Burn, and Early Hemopurifier Progress Support Balanced Risk/Reward and Hold Rating

TIPRANKS
·
Aug 19

Aethlon Medical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity

TIPRANKS
·
Aug 14

Aethlon Medical Q1 FY27 Net Loss Narrows 12.12% to $1.55 Million

Reuters
·
Aug 14

Aethlon Medical Fiscal Q1 2027 results: Lower expenses narrow the net loss

TradingKey
·
Aug 14

Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M

Benzinga Earnings
·
Aug 14

Aethlon Medical Inc: Q1 EPS of $-4.02

THOMSON REUTERS
·
Aug 14

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program

THOMSON REUTERS
·
Aug 14

Aethlon Medical Inc Expected to Post a Loss of 78 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Aethlon Medical Schedules Quarterly Results Release, Conference Call

Reuters
·
Aug 05

Aethlon Medical trading halted, news pending

TIPRANKS
·
Aug 04

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Aug 04

Aethlon Medical Effects 1-for-5 Reverse Stock Split

Reuters
·
Jul 31

Aethlon Medical Reports Biomarker Shifts in Second Cohort of Hemopurifier Cancer Trial

Reuters
·
Jul 13

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®

THOMSON REUTERS
·
Jul 13

Aethlon Medical Prices $4 Million Offering with Warrants Exercisable at $0.71 on Shareholder Approval

Reuters
·
Jul 06

Aethlon Medical Announces Pricing of $4.0 Million Follow-on Offering Priced At-the-market Under NASDAQ Rules

THOMSON REUTERS
·
Jul 06

Aethlon Medical announces publication demonstrating potential of Hemopurifier

TIPRANKS
·
Jun 26

Aethlon Medical Study Flags Long COVID Biomarker, Supports Hemopurifier Evaluation

Reuters
·
Jun 26

Aethlon Medical posts corporate presentation on Hemopurifier blood-filtration platform targeting cancer, viral threats, transplant

Reuters
·
Jun 18